Access Advocacy Cannabinoids Collective 
Veriheal
MAY 26, 2022
Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. RoC also works to increase patients’ access to medical cannabis by helping U.S. Cannabis Advocacy With a Digital Twist.
Veriheal
FEBRUARY 21, 2023
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 26, 2021
VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co Ltd., ( CSE: CRFT ) (“ CRFT ” or the “ Company ”), a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy, is pleased to announce that its subsidiary, FeelWell Brands Inc. BC Craft Supply Co Ltd.
Cannabis Law Report
JUNE 29, 2021
is a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy. BC Craft Supply Co Ltd. The Company offers a reimagined vision for craft markets through collaboration, expertise, and adaptation.
Cannabis Law Report
MAY 18, 2022
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Hemp Roundtable, the hemp industry’s national advocacy organization. “The We are passionate about the science of cannabinoids, and validating CBD safety is the foundation for our innovative products.”
Cannabis Law Report
MAY 18, 2022
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Hemp Roundtable, the hemp industry’s national advocacy organization. “The We are passionate about the science of cannabinoids, and validating CBD safety is the foundation for our innovative products.”
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.
Expert insights. Personalized for you.
98 
Let's personalize your content